Clinical trial · Interventional
Early Interventional Treatment for Cancer Pain
Pilot Study of Early Referral to Interventional Pain Management for Patients With Advanced Malignancies
NCT05366413CI-TRIAL-00088626completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to evaluate how feasible and beneficial it is to refer patients with cancer pain to a doctor who specializes in pain management, including procedures to relieve pain, and whether this is helpful to patients with pain related to their cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Pain | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early Referral | Other | — | UNRESOLVED |
| Pain Management Strategies | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention Arm
- description
- Participants will receive early referral to an anesthesia-trained interventional pain management specialist evaluated for pain management strategies. Participants will complete surveys every 2 months and will have the option of tracking their pain at home using a secure smartphone application. Participants will be followed on the study for 4 months.
- interventionNames
- Other: Early Referral
- Other: Pain Management Strategies
Primary outcomes (3)
- measure
- Feasibility - Pain Consultation
- timeFrame
- 4 Weeks
- description
- Feasibility will be measured by the percentage of patients that have an interventional pain consultation within 4 weeks, with a threshold for determining feasibility of at least 80% of participants.
- measure
- Feasibility - Interventional Pain Procedure Rate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of a metastatic, or locally advanced unresectable malignancy * Anticipated prognosis of more than 6 months according to the primary oncologist * Age greater than 21 years * Persistent pain with an average pain rating of 4 or greater on an 11-point numeric rating scale (NRS) from 0-10 where 10 is considered the most severe. * Pain has persisted for at least 2 weeks * Pain is due to cancer or sequelae of cancer treatment Exclusion Criteria: * Primary pain syndrome is sensory peripheral neuropathy * Patient is taking more than 200 morphine milligram equivalents (MMEs) per day on average, at the time of recruitment. * Currently cared for by interventional pain management specialist * Receipt of prior pain intervention (e.g. celiac neurolysis) * Bleeding diathesis, uncontrollable infection, or other contra-indications to pain interventions * History of opioid misuse disorder * Inability to speak English * Cognitive impairment or any other disorder that would impede study participation and survey completion * If patients are unable to complete the baseline survey, they will no longer be considered eligible for the study; this will serve as an indication of barriers to participation that would make them unable to comply with study procedures.
References
Publications (0)
Data not yet available
No reference posted for this study.